# The Influence of Helicobacter Pylori Eradication on Gastric Pathology: a Long-term, Prospective Cohort Study

> **NCT02933229** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Shandong University** · enrollment: 300 (estimated)

## Conditions studied

- Helicobacter Pylori
- the Operative Link on Gastric Intestinal Metaplasia
- Operative Link on Gastric Intestinal Assessment

## Interventions

- **DEVICE:** biopsy
- **DRUG:** H. pylori eradication

## Key facts

- **NCT ID:** NCT02933229
- **Lead sponsor:** Shandong University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2016-10
- **Primary completion:** 2031-10
- **Final completion:** 2031-10
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2016-10-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02933229

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02933229, "The Influence of Helicobacter Pylori Eradication on Gastric Pathology: a Long-term, Prospective Cohort Study". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT02933229. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
